• Instruct patients to take ella® as soon as possible and not more than 120 hours after unprotected intercourse or a known or suspected contraceptive failure.
• Advise patients that they should not take ella® if they know or suspect they are pregnant and that ella is not indicated for termination of an existing pregnancy.
• Advise patients to contact their healthcare provider immediately in case of vomiting within 3 hours of taking the tablet, to discuss whether to take another tablet.
• Advise patients to seek medical attention if they experience severe lower abdominal pain 3 to 5 weeks after taking ella, in order to be evaluated for an ectopic pregnancy.
• Advise patients to contact their healthcare provider and consider the possibility of pregnancy if their period is delayed after taking ella by more than 1 week beyond the date it was expected.
• Advise patients not to use ella as routine contraception, or to use it repeatedly in the same menstrual cycle.
• Advise patients that ella may reduce the contraceptive action of regular hormonal contraceptives and to use a reliable barrier method of contraception after using ella, for any subsequent acts of intercourse that occur in the same menstrual cycle.
• Inform patients that ella does not protect against HIV infection (HIV) and other sexually transmitted diseases/infections.
•Advise patients that they should not use ella if they are breastfeeding.
PLEASE SEE FULL PRESCRIBING INFORMATION INCLUDING PRECAUTIONS, ADVERSE REACTIONS, AND PATIENT INFORMATION.